George F. Tidmarsh - 08 Feb 2022 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director, 10%+ Owner
Signature
/s/ J.P. Galda, as attorney-in-fact for George F Tidmarsh
Issuer symbol
REVB
Transactions as of
08 Feb 2022
Net transactions value
+$79,139
Form type
4
Filing time
10 Feb 2022, 17:22:45 UTC
Previous filing
09 Feb 2022
Next filing
28 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Purchase $2,540 +1,000 +0.24% $2.54 417,156 08 Feb 2022 Direct
transaction REVB Common Stock Purchase $76,599 +30,000 +7.2% $2.55 447,156 09 Feb 2022 Direct F1
holding REVB Common Stock 1,523,335 08 Feb 2022 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted-average price at which shares were purchased within a range between $2.53 and $2.57. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
F2 Shares are held by George Tidmarsh, Trustee George Francis Tidmarsh 2021 Irrevocable Trust with respect to which George Tidmarsh is a trustee.